Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness

Elevated plasma levels of the osteocyte-derived hormone fibroblast growth factor 23 (FGF23) have emerged as a powerful biomarker of cardiovascular disease and death in patients with CKD. Whether elevated urinary or plasma FGF23 levels are prospectively associated with AKI and death in critically ill...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Am Soc Nephrol
Hlavní autoři: Leaf, David E., Jacob, Kirolos A., Srivastava, Anand, Chen, Margaret E., Christov, Marta, Jüppner, Harald, Sabbisetti, Venkata S., Martin, Aline, Wolf, Myles, Waikar, Sushrut S.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Nephrology 2017
Témata:
Clinical Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5461795/
https://ncbi.nlm.nih.gov/pubmed/28028134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2016080836
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky